Data Quality Management in Pharmacovigilance

[1]  Tiziana Catarci,et al.  Trusting Data Quality in Cooperative Information Systems , 2002, OTM.

[2]  A. Lindquist.  Seeing and observing in international pharmacovigilance: achievements and prospects in worldwide drug safety , 2003 .

[3]  E. Brown,et al.  Methods and Pitfalls in Searching Drug Safety Databases Utilising the Medical Dictionary for Regulatory Activities (MedDRA)1 , 2003, Drug safety.

[4]  Roland Orre.  On Data Mining and Classification Using a Bayesian Confidence Propagation Neural Network , 2003 .

[5]  Bernard Bégaud,et al.  Rates of spontaneous reporting of adverse drug reactions in France. , 2002, JAMA.

[6]  J. Seiler,et al.  Quality management of pharmacology and safety pharmacology studies , 2002, Fundamental & clinical pharmacology.

[7]  J. Peachey.  From Pharmacovigilance to Pharmacoperformance , 2002, Drug safety.

[8]  M. Lindquist,et al.  A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions , 2002, Pharmacoepidemiology and drug safety.

[9]  S. Evans,et al.  Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports , 2001, Pharmacoepidemiology and drug safety.

[10]  H. Tilson,et al.  Proactive safety surveillance , 2001, Pharmacoepidemiology and drug safety.

[11]  M. Lindquist,et al.  A Retrospective Evaluation of a Data Mining Approach to Aid Finding New Adverse Drug Reaction Signals in the WHO International Database , 2000, Drug safety.

[12]  I. Edwards,et al.  Spontaneous ADR reporting and drug safety signal induction in perspective. To honour Professor Jens Schou. , 2000, Pharmacology & toxicology.

[13]  M. Lumpkin.  International pharmacovigilance: developing cooperation to meet the challenges of the 21st century. , 2000, Pharmacology & toxicology.

[14]  William DuMouchel,et al.  Bayesian Data Mining in Large Frequency Tables, with an Application to the FDA Spontaneous Reporting System , 1999 .

[15]  E. Brown,et al.  The Medical Dictionary for Regulatory Activities (MedDRA) , 1999, Drug safety.

[16]  R T O'Neill,et al.  Biostatistical considerations in pharmacovigilance and pharmacoepidemiology: linking quantitative risk assessment in pre-market licensure application safety data, post-market alert reports and formal epidemiological studies. , 1998, Statistics in medicine.

[17]  A. Bate,et al.  A Bayesian neural network method for adverse drug reaction signal generation , 1998, European Journal of Clinical Pharmacology.

[18]  M S Golden,et al.  An incident reporting system: documented at the point of service. , 1998, Journal of healthcare risk management : the journal of the American Society for Healthcare Risk Management.

[19]  D M Coulter,et al.  The New Zealand intensive medicines monitoring programme , 1998, Pharmacoepidemiology and drug safety.

[20]  P. McGettigan,et al.  Reporting of adverse drug reactions by hospital doctors and the response to intervention. , 2003, British journal of clinical pharmacology.

[21]  I. Ralph Edwards,et al.  Principles of Signal Detection in Pharmacovigilance , 1997, Drug safety.

[22]  Diane M. Strong,et al.  Data quality in context , 1997, CACM.

[23]  K. Belton,et al.  Attitude survey of adverse drug-reaction reporting by health care professionals across the European Union , 1997, European Journal of Clinical Pharmacology.

[24]  Richard Y. Wang,et al.  Anchoring data quality dimensions in ontological foundations , 1996, CACM.

[25]  Carlos Martinez,et al.  Concepts in Risk-Benefit Assessment , 1996, Drug safety.

[26]  Thomas Redman,et al.  Data quality for the information age , 1996 .

[27]  Orsini Mj,et al.  An ADR surveillance program: increasing quality, number of incidence reports. , 1995 .

[28]  M D Rawlins,et al.  Pharmacovigilance: Paradise Lost, Regained or Postponed? , 1995, Journal of the Royal College of Physicians of London.

[29]  J. Wack,et al.  Keeping Your Site Comfortably Secure: An Introduction to Internet Firewalls , 1994 .

[30]  H. Valkenburg,et al.  A population based case-cohort study of drug-induced anaphylaxis. , 1993, British journal of clinical pharmacology.

[31]  A Thacher-Renshaw,et al.  Physician reporting of adverse drug reactions. Results of the Rhode Island Adverse Drug Reaction Reporting Project. , 1990, JAMA.

[32]  A. Stergachis.  Record Linkage Studies for Postmarketing Drug Surveillance: Data Quality and Validity Considerations , 1988, Drug intelligence & clinical pharmacy.

[33]  M. Girard.  Data quality in post-marketing surveillance. , 1986, Adverse drug reactions and acute poisoning reviews.